ArticleERJ open research2025
Development and external validation of a model for lung transplantation-free survival prediction of primary Sjögren syndrome-associated interstitial lung disease: a prospective cohort study.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integration of clinical variables and CT radiomics features in a nomogram for predicting interstitial lung disease in Sjögren's syndrome.Journal of thoracic disease · 2026Article
- Serum CA125 is independently associated with adverse outcomes in primary Sjögren's syndrome-associated interstitial lung disease: a prospective multicenter cohort study.Respiratory research · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary Sjögren syndrome-associated interstitial lung disease (pSS-ILD) patients have a worse prognosis than pSS patients without pulmonary involvement. This study aims to establish a prediction nomogram for early prediction of lung transplantation (LTx)-free survival in pSS-ILD patients. Methods: The training cohort comprised 260 patients from China-Japan Friendship Hospital between 1 January 2016 and 30 June 2022, while the external validation cohort consisted of 135 patients from Beijing Chaoyang Hospital between 1 January 2007 and 31 December 2012. Univariable Cox regression analysis and least absolute shrinkage and selection operator were employed for variable selection, and a nomogram model was developed to predict the 1-, 3- and 5-year LTx-free survival. Discrimination and calibration of the nomogram were assessed using the concordance index (C-index), area under the curve, calibration curve and decision curve analysis. Results: Multivariable Cox regression demonstrated that elevated age, oxygenation index, carbohydrate antigen 125 and fibrosis score were independent risk factors for LTx-free survival in pSS-ILD patients. The C-index values for the training and validation cohorts were 0.812 and 0.809, respectively. The 1-, 3- and 5-year AUC values for the training cohort were 0.781, 0.874 and 0.909, respectively, while those for the validation cohort were 0.793, 0.826 and 0.863. The bias-corrected curve was close to the ideal curve and revealed a strong consistency between predicted and observed outcomes. Conclusions: We developed a nomogram capable of predicting the LTx-free survival probability at 1, 3 and 5 years in pSS-ILD patients. This model has the potential to be a useful tool for prediction of death or LTx in pSS-ILD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.